A A A

Canadian team makes stunning diabetic breakthrough

February 16, 2007

Banting and Best

In the 1920′s, two University of Toronto researchers, Banting and Best, made the discovery of insulin which became one of the most revolutionary moments in medicine.

Two months ago, Canadian researchers published another revolutionary finding which will open the door to a potential near-cure of diabetes that affects millions of people around the world. For the first time, they have found a strong link between diabetes, pain nerves, and inflammation.

“In a discovery that has stunned even those behind it, Canadian researchers say they have proof the body’s nervous system helps trigger diabetes type I. Diabetic mice became healthy virtually overnight after researchers injected a neuropeptide to counteract the effect of malfunctioning pain neurons in the pancreas.”

“I couldn’t believe it,” said Dr. Michael Salter, a University of Toronto neuroscientist at the Hospital for Sick Children and one of the team leaders. “Mice with diabetes suddenly didn’t have diabetes any more.”

The team was able to prevent and even reverse diabetes by modulating the neuroinflammatory mechanism without any serious side effects. This mechanism will be further investigated as a possible cause to other autoimmune diseases and may well lead to new treatments and diagnoses for other neuropathic diseases.

Further reading:

  • http://blog.marsdd.com/ Kevin @ MaRS

    Did they patent it? Who owns the rights? I’d imagine Innovations wouldn’t permit such a disclosure without doing so first, but stranger things have happened.

    I somehow doubt they will follow in the footsteps of Banting and Best, selling the rights for $1, making it accessible to all. Gone are the days of such nobility me thinks.

  • Pingback: Biotech Blog » Blog Archive » Carnival of Biotechnology

  • http://blog.marsdd.com/ Lincoln @ MaRS

    Word on the street is that aspects of the research are in the patent process. Depending on the policies at Sickkids, I’m guessing that Sickkids would own at least part and the rest might be shared between the assignees.

  • Pingback: MaRS Blog - Innovation and Commercialization in Canada » Blog Archive » Predicting Diabetes With New Imaging Tracer

  • http://kulvis.com Czes Kulvis

    How could this discovery affect other autoimmune diseases?

  • http://N/A Golam Mosihuddin Sikder-MOHSIN SIKDER

    Word on the street is that aspects of the research are in the patent process. Depending on the policies at Sickkids, I’m guessing that Sickkids would own at least part and the rest might be shared between the assignees.

Lincoln Kim @ MaRS

avatar
Lincoln Kim is a member of the healthcare and life sciences team of the MaRS Venture Group. He evaluates and supports the development of technology platforms and commercial market opportunities of start up and emerging companies, facilitates collaboration among research groups and between research scientists and industry.

More by this author

  • An error has occurred; the feed is probably down. Try again later.

Get More From MaRS

Facebook Twitter Vimeo Flickr

MaRS Charitable Registration Number
876682717 RR0001

MaRS NEWSLETTERS

Please enter your email address to subscribe to our newsletter